Insulin within islets is a physiologic glucagon release inhibitor
- PMID: 6392344
- PMCID: PMC425424
- DOI: 10.1172/JCI111658
Insulin within islets is a physiologic glucagon release inhibitor
Abstract
To determine if glucagon secretion is under physiological control of intra-islet insulin, pancreata from normal rats were perfused at a 100 mg/dl glucose concentration with either guinea pig antiinsulin serum or normal guinea pig serum in a nonrecirculating system. Perfusion of antiserum was followed within 3 min by a significant rise in glucagon that reached peak levels three times the base-line values and assumed a hectic pattern that returned rapidly to base-line levels upon termination of the antiserum perfusion. Nonimmune guinea pig serum had no effect. To gain insight into the probable site of insulin neutralization, 125I-labeled human gamma-globulin was added to antiserum or nonimmune serum and perfused for 3 min. More than 83% of the radioactivity was recovered in the effluent within 3 min after termination of the infusion, and only 0.05 +/- 0.015% of the radioactivity injected was present in the pancreas 10 min after the perfusion. The maximal amount of insulin that could be completely bound to insulin antibody at a dilution and under conditions simulating those of the perfusion experiments was 20 mU/min. It is concluded that insulin maintains an ongoing restraint upon alpha cell secretion and in its absence causes hectic hypersecretion of glucagon. This restraint probably occurs largely in the intravascular compartment. Loss of this release-inhibiting action of insulin may account for initiation of hyperglucagonemia in insulin-deficient states.
Similar articles
-
The alpha cell response to glucose change during perfusion of anti-insulin serum in pancreas isolated from normal rats.Diabetologia. 1985 Nov;28(11):836-40. doi: 10.1007/BF00291074. Diabetologia. 1985. PMID: 3910495
-
Insulin antibody production in guinea pigs is accompanied by disturbances in pancreatic islet morphology and glucagon secretion.Diabete Metab. 1982 Sep;8(3):241-7. Diabete Metab. 1982. PMID: 6754495
-
Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.J Clin Invest. 1976 Nov;58(5):1193-200. doi: 10.1172/JCI108572. J Clin Invest. 1976. PMID: 136453 Free PMC article.
-
Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system.Cell Metab. 2006 Jan;3(1):47-58. doi: 10.1016/j.cmet.2005.11.015. Cell Metab. 2006. PMID: 16399504
-
Glucagon physiology and pathophysiology in the light of new advances.Diabetologia. 1985 Aug;28(8):574-8. doi: 10.1007/BF00281991. Diabetologia. 1985. PMID: 3902546 Review.
Cited by
-
Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists.Diabetes Care. 2016 Jul;39(7):1075-7. doi: 10.2337/dci15-0033. Diabetes Care. 2016. PMID: 27330122 Free PMC article. No abstract available.
-
Regeneration of pancreatic non-β endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin.PLoS One. 2012;7(5):e36675. doi: 10.1371/journal.pone.0036675. Epub 2012 May 7. PLoS One. 2012. PMID: 22586489 Free PMC article.
-
Impact of islet architecture on β-cell heterogeneity, plasticity and function.Nat Rev Endocrinol. 2016 Dec;12(12):695-709. doi: 10.1038/nrendo.2016.147. Epub 2016 Sep 2. Nat Rev Endocrinol. 2016. PMID: 27585958 Review.
-
Conflicting Views About Interactions Between Pancreatic α-Cells and β-Cells.Diabetes. 2023 Dec 1;72(12):1741-1747. doi: 10.2337/db23-0292. Diabetes. 2023. PMID: 37983524 Free PMC article. Review.
-
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.J Clin Invest. 2012 Jan;122(1):4-12. doi: 10.1172/JCI60016. Epub 2012 Jan 3. J Clin Invest. 2012. PMID: 22214853 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials